ABBV

AbbVie News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.70 -0.61% 114.00 15:51:51
Open Price Low Price High Price Close Price Prev Close
114.55 113.96 115.025 114.70
more quote information »

Recent News

Date Time Source Heading
6/23/20217:00IHNWFeaturedThe Emerging Growth / Investors Hub Conference is Today!  Register Now
6/23/20218:30IHNWFeaturedRed Metal Resources Private Placement Oversubscribed with Lead by AlphaNorth Asset Management as Outlook for Copper Soars
6/23/20218:45IHNWFeaturedEsports Technologies Files Patent for Live Streaming Wagering Technology
6/23/20219:00IHNWFeaturedIntegrated Ventures And Wattum Management Partner To Secure 12 Month Purchase Deal For 2,400 WhatsMiners
6/21/202116:03EDGARAnnual Report of Employee Stock Plans (11-k)
6/21/202116:02EDGARAnnual Report of Employee Stock Plans (11-k)
6/18/202102:06SEEKAbbVie declares $1.30 dividend
6/17/202118:29PRNUSAbbVie Declares Quarterly Dividend
6/16/202109:28SEEKZhongchao up 5% as it partners AbbVie's Chinese subsidiary..
6/14/202104:26SEEKJNJ/AbbVie's Imbruvica + Venclexta show promising..
6/12/202107:02PRNUSIMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO®..
6/11/202107:32DJNAbbVie Sees Continued Positive Results for Leukemia..
6/11/202103:19SEEKAbbVie, Roche's Venclexta combo shows sustained benefit in..
6/11/202101:03PRNUSNew Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration..
6/09/202107:14SEEKAbbVie in pact with Caraway Therapeutics for..
6/08/202108:45PRNUSAllergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA)..
6/07/202111:30PRNUSCAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus..
6/07/202107:01PRNCAAbbVie reçoit l'approbation de Santé Canada pour l'emploi de..
6/04/202109:00PRNUSResults from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide..
6/02/202108:30PRNUSAbbVie to Present at the Goldman Sachs 42nd Annual Global..
6/02/202108:00PRNUSPhase 3 Maintenance Results Show Patients with Crohn's..
6/02/202107:30PRNUSAbbVie to Present Analysis Evaluating Continuous RINVOQ®..
6/02/202107:00PRNUSNew Long-Term Efficacy and Safety Analyses Evaluating..
6/01/202117:02EDGARSpecialized Disclosure Report (sd)
5/26/202117:21EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202108:15PRNUSAbbVie to Present at Bernstein's 37th Annual Strategic..
5/26/202108:00PRNUSAbbVie to Present Data from its Leading Migraine Portfolio..
5/25/202109:03DJNAbbVie Gets European Expanded Approval of Venclyxto
5/25/202108:55SEEKAbbVie's Venclyxto combo OK'd in Europe for treatment of..
5/25/202108:00PRNUSAbbVie Receives European Commission Approval of VENCLYXTO®..
5/24/202109:15PRNUSAbbVie Presents New Late-Breaking Data Analyses Showing..
5/24/202108:45PRNUSThe Lancet Publishes Results from Pivotal Global Phase 3..
5/20/202113:51SEEKJNJ highlights potential of IMBRUVICA as a first-line..
5/20/202108:00PRNUSAbbVie to Present at the UBS Global Healthcare Virtual..
5/19/202108:00PRNUSAbbVie to Showcase Breadth of Oncology Portfolio and..
5/18/202116:10DJNHouse Committee Takes on Pricing, Patents for Top-Selling..
5/18/202113:06DJNHouse Committee Takes on Pricing, Patents for Top-Selling..
5/18/202111:26SEEKHouse report alleges drastic drug price hikes,..
5/18/202110:18DJNHouse Committee Takes on Pricing, Patents for Top-Selling..
5/12/202117:13EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/12/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202108:00PRNUSAbbVie to Present at the RBC Capital Markets Global..
5/11/202117:08EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:08EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:08EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:06EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:06EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202117:01EDGARCurrent Report Filing (8-k)
5/10/202109:22DJNAbbVie's Allergan Aesthetics to Buy Soliton
See more news about this stock »


Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.